ORIGINAL RESEARCH article
Front. Oncol.
Sec. Cancer Metabolism
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1598911
Brian [18F]FDG PET Associations of Cervical Cancer-Related Peripheral Inflammatory markers
Provisionally accepted
- 1Department of PET/CT Center, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and the Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China
- 2School of Psychology, Nanjing Normal University, Nanjing, Jiangsu Province, China
- 3Jiangsu Key Laboratory of Mental Health and Cognitive Science, School of Psychology, Nanjing Normal University, Nanjing, Liaoning Province, China
- 4NHC Key Laboratory of Nuclear Medicine and Jiangsu Key Laboratory of Molecular Nuclear Medicine, Wuxi, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The purpose of this study was to explore brain metabolic correlates of peripheral inflammatory markers in patients with cervical cancer (CC).： Cervical cancer (CC) patients (267) without treatments who underwent [18F] Fluorodeoxyglucose ([18F]FDG) positron-emission tomography (PET) / computed tomography (CT) were retrospectively studied. All CC patients were grouped into the International Federation of Gynecology and Obstetrics (FIGO) stage II (n=16), the FIGO stage III (n=160), and the FIGO stage IV (n=91) according to the FIGO stage. According to the median of metabolic tumor volume (MTV) or total lesion glycolysis (TLG) for primary tumor in different FIGO stage, CC patients in different FIGO stage were grouped into the Low_MTV (TLG) group (
Keywords: regional brain glucose metabolism, cervical cancer, Peripheral inflammatory markers, tumor metabolic parameters, PET
Received: 24 Mar 2025; Accepted: 09 Jun 2025.
Copyright: © 2025 Hu, Zhong and Hu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Yuxiao Hu, Department of PET/CT Center, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and the Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.